Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CPAY Corpay	$324.50 -0.5%	$327.64	$247.10 ▼ $400.81	$22.99B	0.98	479,395 shs	333,868 shs
GIB CGI	$106.32 -0.4%	$103.44	$92.85 ▼ $122.79	$24.11B	0.78	201,885 shs	257,431 shs
ICLR ICON Public	$127.99 +0.8%	$149.61	$125.10 ▼ $347.72	$10.34B	1.23	1.05 million shs	883,276 shs
IQV IQVIA	$136.96 -0.8%	$155.33	$134.65 ▼ $252.88	$23.69B	1.34	1.56 million shs	2.25 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CPAY Corpay	-0.52%	-6.92%	+2.93%	-10.77%	+18.96%
GIB CGI	-0.37%	-1.81%	+1.79%	-5.56%	+1.32%
ICLR ICON Public	+0.79%	-2.77%	-10.54%	-36.45%	-59.62%
IQV IQVIA	-0.68%	-3.99%	-6.85%	-28.27%	-39.40%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CPAY Corpay	4.337 of 5 stars	3.4	5.0	0.0	0.0	4.2	1.7	3.1
GIB CGI	3.9031 of 5 stars	3.6	2.0	1.7	0.0	3.7	1.7	2.5
ICLR ICON Public	4.4078 of 5 stars	4.3	5.0	0.0	0.0	1.5	3.3	2.5
IQV IQVIA	4.9468 of 5 stars	4.4	4.0	0.0	4.6	4.0	1.7	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CPAY Corpay	2.75	Moderate Buy	$395.07	21.75% Upside
GIB CGI	3.20	Buy	$156.75	47.43% Upside
ICLR ICON Public	2.60	Moderate Buy	$213.08	66.48% Upside
IQV IQVIA	2.75	Moderate Buy	$228.14	66.57% Upside

Current Analyst Ratings Breakdown

Latest ICLR, IQV, CPAY, and GIB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	IQV IQVIA	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
5/19/2025	IQV IQVIA	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$232.00 ➝ $177.00
5/15/2025	ICLR ICON Public	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$200.00 ➝ $173.00
5/15/2025	IQV IQVIA	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$210.00 ➝ $190.00
5/7/2025	CPAY Corpay	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$417.00 ➝ $414.00
5/7/2025	CPAY Corpay	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$400.00 ➝ $365.00
5/7/2025	IQV IQVIA	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$195.00 ➝ $161.00
5/7/2025	IQV IQVIA	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$255.00 ➝ $185.00
5/7/2025	IQV IQVIA	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$170.00 ➝ $165.00
5/2/2025	ICLR ICON Public	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$165.00 ➝ $155.00
5/2/2025	ICLR ICON Public	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$180.00 ➝ $160.00

(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CPAY Corpay	$4.05B	5.66	$21.71 per share	14.95	$45.13 per share	7.19
GIB CGI	$15.14B	1.59	$6.73 per share	15.80	$31.05 per share	3.42
ICLR ICON Public	$8.19B	1.26	$12.44 per share	10.29	$115.44 per share	1.11
IQV IQVIA	$15.50B	1.53	$11.73 per share	11.68	$34.45 per share	3.98

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CPAY Corpay	$1.00B	$14.26	23.21	14.01	1.32	25.25%	41.46%	7.55%	8/6/2025 (Estimated)
GIB CGI	$1.24B	$5.49	19.23	16.93	2.58	11.72%	19.32%	10.82%	7/30/2025 (Estimated)
ICLR ICON Public	$612.34M	$9.18	13.43	8.37	1.86	9.56%	11.81%	6.65%	7/23/2025 (Estimated)
IQV IQVIA	$1.37B	$7.34	18.26	11.23	1.99	8.91%	28.81%	7.02%	7/28/2025 (Estimated)

Latest ICLR, IQV, CPAY, and GIB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/6/2025	Q1 2025	CPAY Corpay	$4.50	$4.51	+$0.01	$3.40	$1.02 billion	$1.01 billion
5/6/2025	Q1 2025	IQV IQVIA	$2.63	$2.70	+$0.07	$1.40	$3.77 billion	$3.83 billion
4/30/2025	Q2 2025	GIB CGI	$1.50	$1.48	-$0.02	$1.32	$4.05 billion	$2.80 billion
4/30/2025	Q1 2025	ICLR ICON Public	$3.17	$3.19	+$0.02	$1.90	$2.03 billion	$2.00 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CPAY Corpay	N/A	N/A	N/A	N/A	N/A
GIB CGI	$0.41	0.39%	N/A	7.47%	N/A
ICLR ICON Public	N/A	N/A	N/A	N/A	N/A
IQV IQVIA	N/A	N/A	N/A	N/A	N/A

Latest ICLR, IQV, CPAY, and GIB Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2025	GIB CGI	quarterly	$0.1086	0.4%	5/16/2025	5/16/2025	6/20/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CPAY Corpay	1.66	1.00	1.05
GIB CGI	0.28	1.31	1.04
ICLR ICON Public	0.36	1.26	1.34
IQV IQVIA	2.12	0.84	0.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CPAY Corpay	98.84%
GIB CGI	66.68%
ICLR ICON Public	95.61%
IQV IQVIA	89.62%

Insider Ownership

Company	Insider Ownership
CPAY Corpay	5.04%
GIB CGI	9.90%
ICLR ICON Public	44.00%
IQV IQVIA	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CPAY Corpay	10,500	70.49 million	65.46 million	Optionable
GIB CGI	90,000	226.73 million	204.29 million	Optionable
ICLR ICON Public	41,100	80.76 million	46.20 million	Optionable
IQV IQVIA	86,000	173.00 million	173.28 million	Optionable

ICLR, IQV, CPAY, and GIB Headlines

Recent News About These Companies

Medicaid ‘unwinding’ caused disruptions for kids, young adults with chronic illnesses

May 23 at 3:40 PM | healio.com

Global cancer drug sales growth to slow amid patent cliffs: report

May 23 at 3:40 PM | msn.com

IQVIA Holdings Inc. (NYSE:IQV) Shares Acquired by MidWestOne Financial Group Inc.

May 23 at 8:01 AM | marketbeat.com

Study questions precautionary measures on paternal use of valproate

May 23 at 5:38 AM | msn.com

Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease

May 23 at 5:38 AM | physiciansweekly.com

How Target Product Profiles Guide the Industry Through Uncertain Times

May 22 at 10:49 AM | biospace.com

IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Worldquant Millennium Advisors LLC

May 22 at 6:53 AM | marketbeat.com

Twinbeech Capital LP Has $14.56 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

May 22 at 5:33 AM | marketbeat.com

IQVIA Holdings Inc. (NYSE:IQV) Shares Bought by Tidal Investments LLC

May 22 at 5:16 AM | marketbeat.com

Royal Bank of Canada Grows Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)

May 22 at 4:56 AM | marketbeat.com

IQVIA Stock: Is Wall Street Bullish or Bearish?

May 21 at 7:46 PM | msn.com

Sone Capital Management LLC Takes $6.60 Million Position in IQVIA Holdings Inc. (NYSE:IQV)

May 21 at 8:07 AM | marketbeat.com

5,500 Shares in IQVIA Holdings Inc. (NYSE:IQV) Bought by Triglav Skladi D.O.O.

May 21 at 6:55 AM | marketbeat.com

IQVIA Holdings Inc. (NYSE:IQV) Position Increased by Two Sigma Advisers LP

May 21 at 6:46 AM | marketbeat.com

Two Sigma Investments LP Buys 380,933 Shares of IQVIA Holdings Inc. (NYSE:IQV)

May 21 at 6:26 AM | marketbeat.com

Tybourne Capital Management HK Ltd. Grows Stake in IQVIA Holdings Inc. (NYSE:IQV)

May 21 at 6:26 AM | marketbeat.com

Rafferty Asset Management LLC Has $4.02 Million Stake in IQVIA Holdings Inc. (NYSE:IQV)

May 21 at 5:28 AM | marketbeat.com

IQVIA Holdings Inc. (NYSE:IQV) Shares Acquired by ProShare Advisors LLC

May 21 at 5:19 AM | marketbeat.com

Nomura Holdings Inc. Invests $1.12 Million in IQVIA Holdings Inc. (NYSE:IQV)

May 21 at 5:04 AM | marketbeat.com

JPMorgan Chase & Co. Lowers IQVIA (NYSE:IQV) Price Target to $177.00

May 21 at 3:15 AM | americanbankingnews.com

Quantinno Capital Management LP Raises Holdings in IQVIA Holdings Inc. (NYSE:IQV)

May 20, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR, IQV, CPAY, and GIB Company Descriptions

Corpay NYSE:CPAY

$324.50 -1.63 (-0.50%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$320.80 -3.69 (-1.14%)

As of 05/23/2025 04:14 PM Eastern

Corpay, Inc. operates as a payments company that helps businesses and consumers manage vehicle-related expenses, lodging expenses, and corporate payments in the United States, Brazil, the United Kingdom, and internationally. The company offers vehicle payment solutions, which include fuel, tolls, parking, fleet maintenance, and long-haul transportation services, as well as prepaid food and transportation vouchers and cards. It also provides corporate payment solutions consisting of accounts payable automation; virtual cards, cross-border solutions; and purchasing and travel and entertainment card products, as well as lodging payments solutions for employees who travel overnight for work purposes; traveling crews and stranded passengers from airlines and cruise lines; and insurance policyholders displaced from their homes due to damage or catastrophe. In addition, the company offers gifts and payroll cards. It serves business, merchant, consumer, and payment network customers. The company was formerly known as FLEETCOR Technologies, Inc. and changed its name to Corpay, Inc. in March 2024. Corpay, Inc. was founded in 1986 and is headquartered in Atlanta, Georgia.

CGI NYSE:GIB

$106.32 -0.39 (-0.37%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$106.30 -0.02 (-0.02%)

As of 05/23/2025 04:38 PM Eastern

CGI Inc., together with its subsidiaries, provides information technology (IT) and business process services. Its services include the business and strategic IT consulting, systems integration, and software solutions. The company also provides application development, modernization and maintenance, holistic enterprise digitization, automation, hybrid and cloud management, and business process services; intellectual property-based solutions; business consulting; managed IT services; and IT infrastructure services. It serves clients operating in government, banking and capital market, health, utility, communication and media, oil and gas, space, manufacturing, insurance, life sciences, retail and consumer service, and transportation and logistics sectors. The company operates in Canada, France, Spain, Portugal, the United States, Germany, Sweden, Norway, the United Kingdom, Australia, Finland, Poland, Baltics, the Netherlands, Denmark, Czech Republic, India, the Philippines, Asia Pacific, and internationally. Western and Southern Europe; Australia; Scandinavia; Finland, Poland, and Baltics; the United States; the United Kingdom; and the Asia Pacific. The company was formerly known as CGI Group Inc. and changed its name to CGI Inc. in January 2019. CGI Inc. was founded in 1976 and is headquartered in Montreal, Canada.

ICON Public NASDAQ:ICLR

$127.99 +1.00 (+0.79%)

Closing price 05/23/2025 04:00 PM Eastern

Extended Trading

$127.90 -0.09 (-0.07%)

As of 05/23/2025 06:06 PM Eastern

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

IQVIA NYSE:IQV

$136.96 -1.08 (-0.78%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$137.13 +0.16 (+0.12%)

As of 05/23/2025 07:55 PM Eastern

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time